Jump to content


  • Content Count

  • Joined

  • Last visited

  • Country

    United Kingdom

About k1065

  • Rank
    Junior Member
  • Birthday 01/13/1981
  1. Thanks Malcolm, Thats great and very helpful.
  2. In the UK, D testing is performed on donors using antisera capable of detecting DIV, DV and DVI types. Such patients are grouped as RhD positive. This is due to the high likelihood of immunisation should an RhD negative individual recive blood from one of these donors. On the patient testing side, the antisera used for D grouping should not detect DVI and such patients would be grouped as RhD negative. The BSH guidelines specify that antisera which does not detect DVI should be used in pre-transfusion testing however mentions nothing regarding the ability of the antisera to detect DIV and DV. Why on the patient testing side are we not concerned about DIV and DV when such donors are specifically being targeted? Many thanks
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.